Advertisement

Topics

Search Results for "Breast Pap Test Trial"

04:50 EDT 26th June 2017 | BioPortfolio

Matching Channels

Sniff test

Schilling test

Spirometry Test

The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...

Breast Lumps

OncoDEEP

At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...

Matching News

OU and Mercy test new models in largest breast cancer clinical trial in Oklahoma

(University of Oklahoma) A University of Oklahoma and Mercy Hospital Oklahoma City research team is set to begin the largest breast cancer clinical trial ever performed in Oklahoma. The team has devel...

Multi-protein biomarker blood test to detect breast cancer can potentially reduce use of biopsy

A new study published in Clinical Breast Cancer demonstrates that Videssa® Breast, a multi-protein biomarker blood test to detect breast cancer, can help inform better decision-making after abnormal ...

Blood test offers improved breast cancer detection new tool to reduce use of breast biopsy

(Provista Diagnostics) Clinical Breast Cancer study demonstrates Videssa Breast can inform better next steps after abnormal mammogram results & potentially reduce biopsies up to 67%.

Breast Cancer Liquid Biopsy Study Validates Test as Improved Diagnostic Tool

Noninvasive molecular diagnostic techniques are not only the latest cutting-edge technique to help clinicians improve disease prognosis—they are proving to be an essential element for the continued ...

Blood test offers improved breast cancer detection tool to reduce use of breast biopsy

(Provista Diagnostics) A Clinical Breast Cancer study demonstrates Videssa Breast can inform better next steps after abnormal mammogram results and potentially reduce biopsies up to 67 percent.

Provista’s new blood test offers improved breast cancer detection

A new study has demonstrated that a multi-protein biomarker blood test to identify breast cancer can potentially reduce use of biopsy by up to 67% in women under the age of 50.

New models in largest breast cancer clinical trial in Oklahoma

A University of Oklahoma and Mercy Hospital Oklahoma City research team is set to begin the largest breast cancer clinical trial ever performed in Oklahoma. The team has developed new breast cancer ri...

Yale researchers find racial and ethnic disparities in use of genetic test for breast cancer

A genetic test that helps doctors determine how best to treat breast cancer-;and whether chemotherapy is likely to help- is significantly more likely to be administered to white women than blacks or H...

Matching PubMed Articles

First Results of a Phase 2 Trial of Once-Weekly Hypofractionated Breast Irradiation (WHBI) for Early-Stage Breast Cancer.

To report early outcome analysis of a prospective institutional phase 2 trial of weekly hypofractionated breast irradiation (WHBI) for patients undergoing breast-conserving surgery (BCS).

The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer.

SUPREMO is a phase 3 randomised trial evaluating radiotherapy post-mastectomy for intermediate-risk breast cancer. 1688 patients were enrolled from 16 countries between 2006 and 2013. We report the re...

Trial sponsorship and self-reported conflicts of interest in breast cancer radiation therapy: An analysis of prospective clinical trials.

We aim to assess any association between study and self-reported conflict of interest (COI) or trial sponsorship in breast cancer radiation clinical trials.

Trial 1 Versus Trial 2 of the Test of Memory Malingering: Evaluating Accuracy Without a "Gold Standard".

This study examines the accuracy of the Test of Memory Malingering (TOMM), a frequently administered measure for evaluating effort during neurocognitive testing. In the last few years, several authors...

Worry and risk perception of breast cancer in a prevention trial of low dose tamoxifen in midlife postmenopausal hormone users.

There is increasing interest in combining postmenopausal hormone therapy (HT) and SERMs in midlife women. We previously showed that refusal to participate in a prevention trial of low dose tamoxifen i...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement